effects of rosa canina l. fruit on glycemia and lipid profile in type 2 diabetic patients: a randomized, double-blind, placebo-controlled clinical trial

Authors

f hashem dabaghian research institute for islamic and complementary medicine, iran university of medical sciences, tehran iran

m abdollahifard research institute for islamic and complementary medicine, iran university of medical sciences, tehran iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences)

f khalighi sigarudi omid hospital, abhar, zanjan, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences)

m taghavi shirazi omid hospital, abhar, zanjan, iran

abstract

background: rosa canina l. (rose hip) has been traditionally used to treat diabetes mellitus in iran. however, no scientific human study has determined its efficacy in diabetic patients. objective: this study was conducted to evaluate the efficacy and safety of r. canina fruit aqueous extract in type 2 diabetic patients. methods: sixty patients with type 2 diabetes, aged 35 - 60 years with fasting blood glucose levels between 130 to 200 mg/dl and hba1c between 7 - 9% despite using conventional oral hypoglycemic drugs were divided randomly to two groups. two groups of 25 and 23 patients completing the trial received 750 mg r. canina fruit extract and 750 mg toast powder as placebo two times a day respectively for three months. fasting blood glucose (fbg) and glycosylated hemoglobin (hba1c) as primary outcomes and postprandial blood glucose (pbg), lipid profile and hepatic and renal function tests as secondary outcomes were determined at baseline and at endpoint of treatment. the patients were asked to note down any gastrointestinal or other side effects during the study. results: the fbg level decreased significantly (p = 0.002) in r. canina group after 3 months compared to the baseline. in addition total cholesterol/hdl-c was significantly (p = 0.02) decreased in the r. canina group compared to the baseline. other blood parameters were not significantly changed during the study compared with placebo and baseline. no serious side effects were reported in both groups during the study. conclusion: rosa canina 3-month administration to type 2 diabetic patients may reduce fasting blood glucose and total cholesterol/hdl-c without any side effect.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Effects of Rosa canina L. Fruit on Glycemia and Lipid Profile in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Background: Rosa canina L. (rose hip) has been traditionally used to treat diabetes mellitus in Iran. However, no scientific human study has determined its efficacy in diabetic patients. Objective: This study was conducted to evaluate the efficacy and safety of R. canina fruit aqueous extract in type 2 diabetic patients. Methods: Sixty patients with type 2 diabetes, aged 35 - 60 years w...

full text

Effects of Nigella sativa L. Seed Oil in Type II Diabetic Patients: a Randomized, Double-Blind, Placebo - Controlled Clinical Trial

Background: Nigella sativa (N. sativa) seeds are used to treat diabetes mellitus in traditional medicine. Moreover, N. sativa oil has reduced the fasting blood glucose level in non-diabetic volunteers. Objective: The present study was undertaken to explore the possible anti-hyperglycemic effect of N. sativa oil in type II diabetic patients. Methods: A randomized clinical trial was conducted ...

full text

Cynara scolymus L. in Treatment of Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Double-Blind Placebo-Controlled Clinical Trial

Background: Type 2 diabetes mellitus with hyperlipidemia is a common disease. Conventional anti-hyperglycemic and anti-hyperlipidemic drugs have limited efficacies and important side effects, so that alternative agents are needed. Previous studies suggest that fiber-free artichoke (Cynara scolymus L.) leaf extract may have anti-hyperglycemic and anti-hypercholesterolemic effects in hypercholest...

full text

Effects of stevia on glycemic and lipid profile of type 2 diabetic patients: A randomized controlled trial

Objective: Stevia (Stevia rebaudiana Bertoni) is a natural and healthyalternative sweetener to sugar and artificial sweeteners, which has become important for human diets and food manufactures. In this study, the effects of stevia or sucralose as tea sweeteners on glycemic and lipid profile of type 2 diabetic patients were investigated. Materials and Methods:</str...

full text

effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial.

diabetes is a global health problem in the world. probiotic food has anti-diabetic property. the aim of this trial was to determine the effect of probiotic fermented milk (kefir) on glucose and lipid profile control in patients with type 2 diabetes mellitus.this randomized double-blind placebo-controlled clinical trial was conducted on 60 diabetic patients aged 35 to 65 years.patients were rand...

full text

cynara scolymus l. in treatment of hypercholesterolemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial

background: type 2 diabetes mellitus with hyperlipidemia is a common disease. conventional anti-hyperglycemic and anti-hyperlipidemic drugs have limited efficacies and important side effects, so that alternative agents are needed. previous studies suggest that fiber-free artichoke (cynara scolymus l.) leaf extract may have anti-hyperglycemic and anti-hypercholesterolemic effects in hypercholest...

full text

My Resources

Save resource for easier access later


Journal title:
فصلنامه علمی پژوهشی گیاهان دارویی

جلد ۳، شماره ۵۵، صفحات ۹۵-۱۰۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023